It works through a twin device of activity by simulating GLP-1 and triggering another hormonal agent called GIP (Gastric Repressive Polypeptide), which enhances insulin secretion and controls hunger
95% CI 0.620.99) sub-types [22]
Yes, but it has to be used for treating obesity with a doctors approval and LMN
The difference is practical: a larger vial takes longer to use up, which means the last doses drawn may have experienced more cumulative degradation than the first doses
Bottom line: Using Wegovy and Mounjaro together is redundant, not FDA-approved, and carries a high risk of severe gastrointestinal and metabolic complications
5 Genetic and Developmental Medicine Clinic, Sultan Qaboos University Hospital, Muscat, Sultanate of Oman